Recombinant Anti-Human ROR2 (Ozuriftamab)

Specification
Target ROR2
Reactivities Human
Biosimilar Ozubio
Isotype Human IgG1(E356D/M358L/KDel)-kappa
Property Antibody
Alternative receptor tyrosine kinase-like orphan receptor 2, neurotrophic tyrosine kinase receptor-related 2; Neurotrophic tyrosine kinase, receptor-related 2; NTRKR2; NTRKR2tyrosine-protein kinase transmembrane receptor ROR2; receptor tyrosine kinase-like orphan receptor 2; ROR2
Recommend Isotype
Formulation Buffer PBS, pH 7.4,Contains no stabilizers or preservatives
Recommend Buffer PBS, pH 7.4,Contains no stabilizers or preservatives.
Endotoxin <1EU/mg Determined by LAL gel clotting assay
Purity >95% Determined by SDS-PAGE
Sterility 0.2 μM filtered
Expression Host CHO
Purification method Protein A
Storage The product should be stored at the original stock concentration at 4°C. Avoid freeze-thaw cycles.
Note Due to the variability in applications, investigators should consult application references to estimate the appropriate dose or concentration. This dose or concentration can then be further optimized through experimental methods such as dose-response or titration experimentsThe sequence of this product comes from:IMGT
Background
QC Data
Note Please contact us for QC Data
Product Image (Reference Only) antibody
$252.00
In stock
SKU
EB-EB25101

Recombinant Anti-Human ROR2 (Ozuriftamab) For Research Use Only

Question / Bulk Inquiry
Please leave us a message if you have any questions or have bulk order inquiry, we will get back to you in 24 hours.
Please type the letters and numbers below

 

Reviews

Write Your Own Review
You're reviewing:Recombinant Anti-Human ROR2 (Ozuriftamab)
Copyright © 2021-present Echo Biosystems. All rights reserved.